Trihexyphenidyl for dystonia in cerebral palsy
Part of Brain & nervous system clinical trials.
This study tests how a medicine called trihexyphenidyl works in children with dystonic cerebral palsy, a condition that causes muscle spasms. Researchers want to learn if a child’s genes affect how the medicine works and how the body processes it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must be between 5 and 17 years old
- Your child must have cerebral palsy with dystonia (stiff or twisting muscles) that causes problems
- You, as a parent or guardian, must be willing to give permission for your child to join
- Your child cannot have taken trihexyphenidyl before
- Your child must not turn 18 during the 16-week study period
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at ways to improve how the brain processes movement in children and young people with dystonia. You may be asked to complete study tasks while researchers compare people with dystonia to similar children without movement disorders.
This study looks at how different types of dystonia (movement disorders) relate to genetics and brain findings from scans. You might help researchers understand why symptoms look different from person to person and what patterns may matter.
This study measures brain signals in children with dystonia to understand how the brain controls movement, with the goal of improving treatments like Deep Brain Stimulation (DBS). It also uses healthy children for comparison.
This trial tests if focused ultrasound can help reduce uncontrolled movements in children and young adults with cerebral palsy caused by a lack of oxygen at birth. It may offer an option for those whose current medications aren't working well enough.
This study tracks people with dystonia who get deep brain stimulation (DBS) using a special device that can sense brain signals. It aims to see how well the treatment works over time and why it helps some people more than others.
This study tests whether L-dopa medication can help children with a rare genetic disorder (caused by changes in the CTNNB1 gene) that causes involuntary muscle movements called dystonia. Researchers want to see if this medicine can reduce these movements and improve daily function.
Hear when a new Pediatric Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.